SKIMS conquers “Suicide Disease”; successfully treats 26 patients with state-of-the-art procedure

STC NEWS DESK
SRINAGAR, DECEMBER 27 (STC): Sher-i-Kashmir Institute of Medical Sciences (SKIMS) has achieved a major clinical success with its Department of Neurosurgery treating one of the most severe forms of facial pain — Trigeminal Neuralgia, commonly known as the “Suicide Disease.”
A statement issued to media reads that the SKIMS is among the few centers in India – and the only center in Jammu & Kashmir – offering treatment for such patients through a highly specialized microsurgical procedure called Microvascular Decompression (MVD) with Teflon graft interposition.
Director SKIMS and Ex-Officio Secretary to the Government, Prof. M. Ashraf Ganie, congratulated the neurosurgery team led by Prof. (Dr) Nayil Khursheed, with support from Dr Bashir A. Dar, Dr Zulfikar Ali, Dr Malik Jauhar, Dr Aamir Hela, Mr Muhammad Yaqoob, Mrs Roohi Malik, and Mrs Nazima Khan.
He emphasized that patients suffering from this debilitating condition no longer need to travel outside J&K and directed the department to work in coordination with neurologists, neurosurgeons, and general physicians to ensure structured, timely care for all referred patients.
Giving details of the treatment given to the patients, the statement reads: To date, 26 patients with Trigeminal Neuralgia have been successfully treated at SKIMS. These patients were referred from peripheral health centers and had not responded to medications or other treatment modalities. Many had reached the limits of their tolerance due to unbearable pain. This year alone, seven patients underwent surgery, including a female patient from Jammu who had endured intractable facial pain for nearly ten years and had undergone multiple dental procedures without relief.Following treatment, all patients have returned to normal, independent lives and resumed routine daily activities.
The consistently high success rate of this complex neurosurgical procedure at SKIMS offers a major relief to patients who would otherwise have had to travel outside the region, facing significant inconvenience, emotional distress, and financial burden.

(Straight Talk Communications)